title: Gene expression is altered in the lateral hypothalamus upon activation of the mu opioid receptor.
abstract: The lateral hypothalamus (LH) is a brain structure that controls hedonic properties of both natural rewards and drugs of abuse. Mu opioid receptors are known to mediate drug reward, but whether overstimulation of these receptors impacts on LH function has not been studied. Here we have used a genome-wide microarray approach to identify LH responses to chronic mu opioid receptor activation at the transcriptional level. We have subjected wild-type and mu opioid receptor knockout mice to an escalating morphine regimen, which produces severe physical dependence in wild-type but not mutant animals. We have analyzed gene profiles in LH samples using the 430A.2 Affymetrix array and identified a set of 25 genes whose expression is altered by morphine in wild-type mice only. The regulation was confirmed for a subset of these genes using real-time quantitative PCR on samples from independent treatments. Altered expression of aquaporin 4, apolipoprotein D, and prostaglandin synthase is indicative of modified LH physiology. The regulation of two signaling genes (the serum glucocorticoid kinase and the regulator of G protein signaling 4) suggests that neurotransmission is altered in LH circuitry. Finally, the downregulation of apelin may indicate a potential role for this neuropeptide in opioid signaling and hedonic homeostasis. Altogether, our study shows that chronic mu opioid receptor stimulation induces gene expression plasticity in the LH and provides a unique collection of mu opioid receptor-dependent genes that potentially contribute to alter reward processes in addictive diseases.
authors.affiliation: Institut de Génétique et de Biologie Moléculaire et Cellulaire, Département Neurobiologie et Génétique, Illkirch, France. befort@igbmc.u-strasbg.fr
authors.forename: K
authors.initials: K
authors.lastname: Befort
authors.forename: D
authors.initials: D
authors.lastname: Filliol
authors.forename: E
authors.initials: E
authors.lastname: Darcq
authors.forename: A
authors.initials: A
authors.lastname: Ghate
authors.forename: A
authors.initials: A
authors.lastname: Matifas
authors.forename: A
authors.initials: A
authors.lastname: Lardenois
authors.forename: J
authors.initials: J
authors.lastname: Muller
authors.forename: C
authors.initials: C
authors.lastname: Thibault
authors.forename: D
authors.initials: D
authors.lastname: Dembele
authors.forename: O
authors.initials: O
authors.lastname: Poch
authors.forename: B L
authors.initials: BL
authors.lastname: Kieffer
mesh_terms: D000818:Animals; D005786:Gene Expression Regulation / Q000187:drug effects; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009020:Morphine / Q000494:pharmacology; D016133:Polymerase Chain Reaction; D017450:Receptors, Opioid, mu / Q000235:genetics* / Q000378:metabolism; D015203:Reproducibility of Results
chemical_list: D017450:Receptors, Opioid, mu; D009020:Morphine